Description		Purified Polyclonal Antibody against Herpes Simplex Virus (HSV) (Formerly Signet Catalog Nos: 435-01, 435-16 L1 Predilute, 435-26 L2 Predilute)
Intended Use		** In Vitro Diagnostic (IVD) **
Form		Purified Antibody (in 0.01M PBS + 0.1% NaN3 + 1% BSA)
Host		Rabbit
Species Reactivity		Human
Specificity		The Signet anti-Herpes Simplex Virus (HSV) I and II antibody reacts with HSV infected tissues and tissue culture preparations. The HSV I and II antibody has been found to crossreact with the varicella zoster virus. This antibody was developed using rabbit-cornea cells (continuous cell line) infected with HSV Type 1 (detergent solubilized, strain Mac Intyre). Concentrated Format: SIG-3435-1000 [1 mL] Prediluted Formats: SIG-3435-16 [6 mL] SIG-3435-26 [6 mL] is ready-to-use with Biotin-based detection systems such as Signet's USA Ultrastreptavidin Detection (SIG-32250).
Uses		This antibody is effective in immunohistochemistry (IHC).
Suggested Working Dilution		The optimal working dilution should be determined for each specific assay condition. IHC: ≥1:40 (concentrated format) for Biotin based detection systems such as Signet's USA Ultrastreptavidin Detection (SIG-32250). Tissue Sections: Formalin-fixed, paraffin-embedded tissues Pretreatment: Not required Incubation: 20 minutes at room temperature
Notes		Positive tissue (human): HSV infected tissues and cell preps
Storage		Store between 2-8°C.
Warranty/Conditions		Covance products may not be resold or modified for resale without prior written approval.
Rev. Date		8/7/2007